Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 15.7M | 23.8M | 18.1M | 17.0M |
Other operating expenses | — | — | — | — |
Operating income | -16.3M | -24.4M | -18.7M | -17.6M |
Non operating interest income | ||||
Income | 4.1M | 6.0M | 6.3M | 5.9M |
Expense | 11.6M | 11.8M | 11.3M | 6.1M |
Other income expense | -16.5M | -37.2M | 33.5M | 27.6M |
Pretax income | -40.3M | -67.4M | 9.7M | 9.8M |
Tax provision | 10.7M | -1.0M | -511K | -3.4M |
Net income | -50.9M | -66.4M | 10.3M | 13.2M |
Basic EPS | -0.1 | — | 0.0 | 0.0 |
Diluted EPS | -0.1 | — | 0.0 | 0.0 |
Basic average shares | 569.1M | — | 564.7M | 551.5M |
Diluted average shares | 569.1M | — | 621.9M | 613.8M |
EBITDA | 61.0M | -57.4M | 22.4M | 16.5M |
Net income from continuing op. | -50.9M | -66.4M | 10.3M | 13.2M |
Minority interests | — | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |